DNTH
Dianthus Therapeutics Inc.
NASDAQ: DNTH · HEALTHCARE · BIOTECHNOLOGY
$87.12
+0.47% today
Updated 2026-05-11
Market cap
$4.76B
P/E ratio
—
P/S ratio
3,564.76x
EPS (TTM)
$-4.23
Dividend yield
—
52W range
$17 – $97
Volume
1.0M
Dianthus Therapeutics Inc. (DNTH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-10,050.00%
ROE
-22.70%
ROA
-15.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | — | $-9.43M | — | — | — |
| 2017 | — | $-35.49M | — | — | — |
| 2018 | — | $-57.52M | — | — | — |
| 2019 | — | $-76.77M | — | — | — |
| 2020 | — | $-74.94M | — | — | — |
| 2021 | $1.48M | $-13.11M | 100.00% | -886.59% | -888.14% |
| 2022 | $6.42M | $-28.48M | 100.00% | -462.91% | -443.76% |
| 2023 | $2.83M | $-43.55M | 100.00% | -1,704.67% | -1,541.22% |
| 2024 | $6.24M | $-84.97M | 100.00% | -1,633.74% | -1,362.77% |
| 2025 | $2.04M | $-162.34M | 100.00% | -8,739.34% | -7,973.33% |